When to test women for human papillomavirus: Take this opportunity to screen for anal cancer too [9]

British Medical Journal

Volumn 332, Issue 7535, 2006, Pages 237-

  Hayanga, Awori J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CANCER; ANUS INTERCOURSE; CANCER INCIDENCE; CANCER SCREENING; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LETTER; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS; ANUS TUMOR; MASS SCREENING; METHODOLOGY; PAPILLOMA VIRUS; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ANUS NEOPLASMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 31644437530     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7535.237-a     Document Type: Letter

References (3)

1. Legood R, Gray A, Wolstenhokne J, Moss S. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: modelling study. BMJ 2006;332:79-85. (14 January.)
2. Chang GJ, Berry M, Jay N, Palefsky, JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002 Apr;45(4):453-8
3. Hernandez B, McDuffie K, Zhu X, Wilkens LR, Killeen J, Kesse B, et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005;14(11 Pt 1):2550-6.